OGRIX
Price
$32.93
Change
-$0.04 (-0.12%)
Updated
Jun 5 closing price
Net Assets
734.72M
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.22B
Interact to see
Advertisement

OGRIX vs RMEBX

Header iconOGRIX vs RMEBX Comparison
Open Charts OGRIX vs RMEBXBanner chart's image
Invesco Comstock Select R6
Price$32.93
Change-$0.04 (-0.12%)
VolumeN/A
Net Assets734.72M
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.22B
OGRIX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
OGRIX vs. RMEBX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGRIX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. OGRIX (735M). OGRIX pays higher dividends than RMEBX: OGRIX (1.97) vs RMEBX (1.16). OGRIX was incepted earlier than RMEBX: OGRIX (13 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than OGRIX (0.60). OGRIX is a more actively managed with annual turnover of: 104.00 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than OGRIX: RMEBX (250) vs OGRIX (1000000). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. OGRIX (-5.30). RMEBX return over 5 years is better than : 49.85 vs. OGRIX (42.50).
OGRIXRMEBXOGRIX / RMEBX
Total Expense Ratio0.591.0755%
Annual Report Gross Expense Ratio0.601.0756%
Fund Existence13 years11 years-
Gain YTD2.1925.34941%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets735M105B1%
Annual Yield % from dividends1.971.16170%
Returns for 1 year-5.308.30-64%
Returns for 3 years-4.5717.96-25%
Returns for 5 years42.5049.8585%
Returns for 10 years17.1868.2125%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA